← Azimuth Daily
Capturing data…
Capturing data…
FRI, 13 NOV · 80 ITEMS
"RSV vaccines slash hospitalizations, new data shows" — Nature (current) · Science & Medicine
This Nature news article reports that real-world data from multiple studies, including a large Danish registry trial and a U.S. Veterans Health Administration study, show that vaccines (such as the from Pfizer and Moderna's mRNA-based vaccine) are highly effective at preventing severe RSV illness, cutting hospitalizations and emergency department visits by 81% in the first year and 64% in the second year among older adults. The data also indicate that are reducing infant hospitalizations. The headline's 'slash' reflects a dramatic, population-level impact, not a modest effect.
The claim is solid, grounded in peer-reviewed studies published in Nature and other journals, with the Danish national registry trial and VA target trial providing high-quality real-world evidence. The reporting in Nature is a news summary directly based on these primary sources, so the accuracy of the core finding is high, though the headline's 'slash' is a journalistic framing rather than a precise quantitative claim.
The underlying studies and this Nature news article are genuinely new, published in late 2025 and 2026, with the search results showing articles from September 2025 through November 2026, indicating ongoing accumulation of evidence.